Posted on 8/3/20
Immunic Proposes Public Offering of 5M Shares of Common Stock
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced . . .
Posted on 8/3/20
Dr. Rohan Ramakrishna Appointed Chief of Neurological Surgery at NewYork-Presbyterian Brooklyn Methodist Hospital
Dr. Rohan Ramakrishna has been appointed chief of neurological surgery at NewYork-Presbyterian Brooklyn Methodist Hospital. Dr. Ramakrishna, who is also the Alvina and Willis Murphy Associate . . .
Posted on 8/3/20
NewYork-Presbyterian Alexandra Cohen Hospital for Women and Newborns Opens
Providing a full range of services before, during, and after childbirth, including high-risk pregnancy care and the highest level of critical care for newbornsNewYork-Presbyterian today celebrated . . .
Posted on 8/3/20
BlueCrest Capital Management Transitions to SS&C for Multi-Asset Execution Management
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced BlueCrest Capital Management has selected SS&C Eze to power its trading.SS&C Eze's EMS stood out with its advanced . . .
Posted on 8/3/20
Advaxis Announces Common Stock Purchase Agreement for up to $20 Million with Lincoln Park Capital
PRINCETON, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today . . .
Posted on 8/3/20
PMV Pharma Closes $70 Million in Series D Financing
PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations, announced the completion of a $70 . . .
Posted on 8/3/20
Merck Animal Health Completes Acquisition of Worldwide Rights to VECOXAN Brand of Parasiticides for Ruminant Portfolio
MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA . . .
Posted on 8/3/20
Protara Therapeutics Announces Second Quarter 2020 Financial Results and Business Overview
NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a development-stage company developing treatments for rare and specialty diseases with significant unmet . . .
Posted on 8/3/20
2020’s Best & Worst States for Health Care – WalletHub Study
The COVID-19 pandemic has impacted medical care in countless ways, from postponing elective surgeries to moving many visits online. To shed some light on where people . . .
Posted on 8/3/20
Merck: Potential Biden Win Worrisome
SummaryMerck's EPS growth forecast for 2020-22 is subpar at best vs. the big pharma industry.Socialized medicine and drug price controls could become reality next year, if . . .
Posted on 8/3/20
Merck's Q2 Sales Got Clobbered by COVID-19, but Still Beat Estimates
So far, 2020 has not turned out like Merck (NYSE:MRK) hoped it would: The big drugmaker's blockbuster oncology treatment Keytruda flopped in late-stage studies targeting bladder . . .
Posted on 8/3/20
Merck to Begin Pivotal COVID-19 Antiviral Studies in September
During Merck's (NYSE:MRK) second-quarter earnings call on Friday, the company's head of research and development discussed progress on a potential new treatment for COVID-19 patients. The . . .
Posted on 8/3/20
Better Buy: Gilead Sciences vs. Pfizer
Gilead Sciences (NASDAQ:GILD) and Pfizer (NYSE:PFE) are two of the most competent pharmaceutical companies in the industry. Both have impressively broad and advanced drug development pipelines, . . .
Posted on 8/3/20
3 Reasons to Buy Pfizer
The COVID-19 pandemic has made this a unique time to invest in healthcare stocks. Some companies in the sector have already seen remarkable rallies thanks to . . .
Posted on 8/3/20
Better Coronavirus Stock: Pfizer or Inovio Pharmaceuticals?
There are no signs the coronavirus pandemic is slowing down in the U.S., with more than 1,100 Americans dying every day from COVID-19 in recent days. . . .
Posted on 8/3/20
How Vertex Pharmaceuticals Wowed With Its Q2 Results
Vertex Pharmaceuticals (NASDAQ:VRTX) has been on a roll so far in 2020. The big biotech delivered strong growth in the first quarter. It received a positive . . .
Posted on 8/2/20
Zentalis Pharmaceuticals Prices Upsized Offering of Common Stock
NEW YORK and SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small . . .
Posted on 7/31/20
DarioHealth Announces $28.6 Million Private Placement
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it closed a private placement transaction with accredited investors, including healthcare . . .
Posted on 7/31/20
Johnson & Johnson Will Be Worth Buying After A Pullback
SummaryAn AAA-rated company with a wonderful balance sheet makes buying its stock seem to be a very low risk investment.It is pointless to expect impressive growth . . .
Posted on 7/31/20
Johnson & Johnson's Coronavirus Vaccine Candidate Efficacious in Pre-Clinical Studies; Human Testing Has Begun
Johnson & Johnson (NYSE:JNJ) has gained some ground in the coronavirus vaccine race. On Thursday, the pharmaceutical and consumer goods company announced that in pre-clinical studies, . . .
Posted on 7/31/20
Why Teladoc Health's Q2 Earnings Miss Isn't As Bad As It Seems
No one can complain about Teladoc Health's (NYSE:TDOC) performance so far in 2020. Business is booming for the telehealth services leader. Its share price has skyrocketed . . .
Posted on 7/31/20
Teladoc Earnings: 5 Key Metrics Investors Should See
Teladoc Health (NYSE:TDOC), the global leader in virtual healthcare, reported powerful second-quarter 2020 results after the market closed on Wednesday.Shares were down 1.5% in after-hours trading . . .
Posted on 7/31/20
Teladoc Health Delivers a Mixed Q2 Report
Fueled by the sudden and acute increase in the need for its services during the coronavirus pandemic, Teladoc Health (NYSE:TDOC) has experienced a surge in revenue . . .
Posted on 7/31/20
Why Teladoc Health Stock Jumped on Thursday
What happenedShares of Teladoc Health (NYSE:TDOC) jumped on Thursday, rising about 6% as of 1:40 p.m. EDT. The stock's gain came after the company announced second-quarter . . .
Posted on 7/30/20
Rectangle Health and ARC Fertility Partner
Rectangle Health and ARC Fertility are pleased to announce their partnership to provide a sophisticated, digital patient experience that improves payment capture and brings efficiency to . . .
New York
